Ubs Group Ag Ironwood Pharmaceuticals Inc Call Options Transaction History

Ubs Group Ag

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	SELL	$5.58 - $8.61 $62.5 Million - $96.4 Million	-11,200,320 Reduced 50.0%	11,200,320 $73 Million
Q1 2024 May 13, 2024	BUY	$8.32 - $15.45 $186 Million - $346 Million	22,400,640 New	22,400,640 $195 Million
Q4 2020 Feb 11, 2021	BUY	$9.05 - $12.2 $276,930 - $373,320	30,600 New	30,600 $349,000

237

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $706M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.